Chicago Equity Partners’s Emergent Biosolutions EBS Stock Holding History

Chicago Equity Partners’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-49,640	Closed	-$2.51M	–	913
2019 Q1	$2.51M	Sell	49,640 -355	-0.7%	-$20.9K	0.1%	298
2018 Q4	$2.96M	Sell	49,995 -13,280	-21%	-$856K	0.12%	242
2018 Q3	$4.17M	Sell	63,275 -11,665	-16%	-$681K	0.12%	232
2018 Q2	$3.78M	Sell	74,940 -40,620	-35%	-$2.12M	0.12%	262
2018 Q1	$6.08M	Buy	115,560 +6,070	+6%	+$303K	0.19%	153
2017 Q4	$5.09M	Buy	109,490 +63,125	+136%	+$2.66M	0.16%	187
2017 Q3	$1.88M	Buy	+46,365	New	+$1.68M	0.06%	381
2015 Q4	–	Sell	-34,725	Closed	-$989K	–	603
2015 Q3	$989K	Buy	+34,725	New	+$1.14M	0.03%	368

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Chicago Equity Partners's EBS Position: Q2 2019 in Review

Chicago Equity Partners sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 49,640 shares — an estimated $2.51M sold.

Chicago Equity Partners first reported a position in EBS in Q3 2015 and held it in 8 quarters. The position peaked at $6.08M in Q1 2018. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

Chicago Equity Partners reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
Chicago Equity Partners sold 49,640 Emergent Biosolutions shares in Q2 2019, an estimated $2.51M.
Chicago Equity Partners first reported a position in Emergent Biosolutions in Q3 2015 and held it in 8 quarters.
Chicago Equity Partners's Emergent Biosolutions position peaked at $6.08M in Q1 2018.
233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on Chicago Equity Partners's 13F filing for Q2 2019, filed 2 Aug 2019.